암과 신경퇴행성 질환의 관련성: 국민건강보험공단 맞춤형 DB를 이용한 후향적 코호트 연구

키워드

참고문헌 (52)

1. Wong RS, "Apoptosis in cancer : from pathogenesis to treatment", J Exp Clin Cancer Res, 30, pp.87~ (2011)
2. Harris CC, "Clinical implications of the p53 tumor-suppressor gene", N Engl J Med, 329, pp.1318~1327 (1993)
3. Haupt S, "Apoptosis-the p53 network", J Cell Sci, 116, pp.4077~4085 (2003)
4. Ross CA, "Protein aggregation and neurodegenerative disease", Nat Med, 10 Suppl, pp.S10~S17 (2004)
5. Dobson CM, "Protein folding and misfolding", Nature, 426, pp.884~890 (2003)
6. Ganguli M, "Cancer and dementia : it’s complicated", Alzheimer Dis Assoc Disord, 29, pp.177~182 (2015)
7. Ji Eun Lee, "Association between Alzheimer’s Disease and Cancer Risk in South Korea: an 11-year Nationwide Population-Based Study", Dementia and Neurocognitive Disorders(대한치매학회지), 17(4), pp.137~147 (2018), 대한치매학회[DOI]
8. Musicco M, "Inverse occurrence of cancer and Alzheimer disease : a population-based incidence study", Neurology, 81, pp.322~328 (2013)
9. Driver JA, "Inverse association between cancer and Alzheimer’s disease: results from the Framingham Heart Study", BMJ, 344, pp.e1442~ (2012)
10. Yarchoan M, "Association of cancer history with Alzheimer’s disease dementia and neuropathology", J Alzheimers Dis, 56, pp.699~706 (2017)
11. Lin HL, "Inverse association between cancer and dementia : a population-based registry study in Taiwan", Alzheimer Dis Assoc Disord, 30, pp.118~122 (2016)
12. Boursi B, "Parkinson’s disease and colorectal cancer risk-A nested case control study", Cancer Epidemiol, 43, pp.9~14 (2016)
13. Jespersen CG, "Parkinson’s disease and risk of prostate cancer: a Danish population-based case-control study, 1995-2010", Cancer Epidemiol, 45, pp.157~161 (2016)
14. Ryu HJ, "Parkinson’s disease and skin cancer risk: a nationwide population-based cohort study in Korea", J Eur Acad Dermatol Venereol, 34, pp.2775~2780 (2020)
15. Wirdefeldt K, "Parkinson’s disease and cancer : a register-based family study", Am J Epidemiol, 179, pp.85~94 (2014)
16. Zhang P, "Association between Parkinson’s disease and risk of cancer : a PRISMA-compliant meta-analysis", ACS Chem Neurosci, 10, pp.4430~4439 (2019)
17. Tacik P, "Cancer in Parkinson’s disease", Parkinsonism Relat Disord, 31, pp.28~33 (2016)
18. Bajaj A, "Parkinson’s disease and cancer risk : a systematic review and meta-analysis", Cancer Causes Control, 21, pp.697~707 (2010)
19. Feng DD, "The associations between Parkinson’s disease and cancer : the plot thickens", Transl Neurodegener, 4, pp.20~ (2015)
20. Rojas NG, "Neurodegenerative diseases and cancer : sharing common mechanisms in complex interactions", J Integr Neurosci, 19, pp.187~199 (2020)
21. Driver JA, "Understanding the link between cancer and neurodegeneration", J Geriatr Oncol, 3, pp.58~67 (2012)
22. Du L, "Cancer and neurodegenerative disorders : pathogenic convergence through microRNA regulation", J Mol Cell Biol, 3, pp.176~180 (2011)
23. Scott MD, "Aberrant protein folding as the molecular basis of cancer", Methods Mol Biol, 232, pp.67~76 (2003)
24. Navalkar A, "Prion-like p53 amyloids in cancer", Biochemistry, 59, pp.146~155 (2020)
25. Roffman CE, "Charlson comorbidities index", J Physiother, 62, pp.171~ (2016)
26. StataCorp, "Stata statistical software. Release 16" (2019), Stata-Corp LLC
27. 2015 National health insurance statistical yearbook, "Son MS", Health Insurance Review & Assessment Service, National Health Insurance Service, ~ (2016)
28. Freedman DM, "Associations between cancer and Alzheimer’s disease in a U.S. Medicare population", Cancer Med, 5, pp.2965~2976 (2016)
29. Hanson HA, "Is cancer protective for subsequent Alzheimer’s disease risk? Evidence from the Utah population database", J Gerontol B Psychol Sci Soc Sci, 72, pp.1032~1043 (2017)
30. Park JH, "Cancer risk in patients with Parkinson’s disease in South Korea: a nationwide, population-based cohort study", Eur J Cancer, 117, pp.5~13 (2019)
31. Comparative study of Parkinson’s disease and the risk of cancer in Koreans, "Lee JE", NHIS Ilsan Hospital Institute of Health Insurance & Clinical Research, 1~55 (2017)
32. Ariga H, "Common mechanisms of onset of cancer and neurodegenerative diseases", Biol Pharm Bull, 38, pp.795~808 (2015)
33. de Moura MB, "Mitochondrial dysfunction in neurodegenerative diseases and cancer", Environ Mol Mutagen, 51, pp.391~405 (2010)
34. Seo J, "Molecular crosstalk between cancer and neurodegenerative diseases", Cell Mol Life Sci, 77, pp.2659~2680 (2020)
35. Angelucci F, "Prolyl isomerase Pin1 and neurotrophins : a loop that may determine the fate of cells in cancer and neurodegeneration", Ther Adv Med Oncol, 9, pp.59~62 (2017)
36. Gong H, "Amyloidogenicity of p53 : a hidden link between protein misfolding and cancer", Curr Protein Pept Sci, 16, pp.135~146 (2015)
37. Rangel LP, "The aggregation of mutant p53 produces prion-like properties in cancer", Prion, 8, pp.75~84 (2014)
38. de Oliveira GA, "Misfolding, aggregation, and disordered segments in c-Abl and p53 in human cancer", Front Oncol, 5, pp.97~ (2015)
39. Lanni C, "p53 at the crossroads between cancer and neurodegeneration", Free Radic Biol Med, 52, pp.1727~1733 (2012)
40. Oakes SA, "Endoplasmic reticulum proteostasis : a key checkpoint in cancer", Am J Physiol Cell Physiol, 312, pp.C93~C102 (2017)
41. Galmiche A, "Role of the unfolded protein response in tumor cell characteristics and cancer outcome", Curr Opin Oncol, 29, pp.41~47 (2017)
42. Arpalahti L, "Proteostasis dysregulation in pancreatic cancer", Adv Exp Med Biol, 1233, pp.101~115 (2020)
43. Höhn A, "Proteostasis failure in neurodegen erative diseases : focus on oxidative stress", Oxid Med Cell Longev, 2020, pp.5497046~ (2020)
44. Wang M, "The impact of the endoplasmic reticulum protein-folding environment on cancer development", Nat Rev Cancer, 14, pp.581~597 (2014)
45. Sabath N, "Cellular proteostasis decline in human senescence", Proc Natl Acad Sci U S A, 117, pp.31902~31913 (2020)
46. Johnson JA, "Time-varying incidence of cancer after the onset of type 2 diabetes : evidence of potential detection bias", Diabetologia, 54, pp.2263~2271 (2011)
47. Wang M, "Cancer risk among patients with type 2 diabetes mellitus: a population-based prospective study in China", Sci Rep, 5, pp.11503~ (2015)
48. Dankner R, "Time-dependent risk of cancer after a diabetes diagnosis in a cohort of 2.3 million adults", Am J Epidemiol, 183, pp.1098~1106 (2016)
49. Pendergrass JC, "Cognitive impairment associated with cancer : a brief review", Innov Clin Neurosci, 15, pp.36~44 (2018)
50. Lange M, "Cancerrelated cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors", Ann Oncol, 30, pp.1925~1940 (2019)
51. Nail LM, "Fatigue and weakness in cancer patients : the symptoms experience", Semin Oncol Nurs, 11, pp.272~278 (1995)
52. Garland SN, "Are sleep continuity disturbance and fatigue prodromal symptoms of cancer development?", Med Hypotheses, 120, pp.72~75 (2018)

관련 논문AI추천